Clinical Study No. DRI10734, [......] tolerability of SAR110894D at the doses of 0.5 mg, 2 mg, and 5 mg/day for 24 weeks in patients with mild to moderate Alzheimer's Disease on stable donepezil (2011–2013)

Grant type:
Sanofi-Aventis Australia Pty Ltd
Researchers:
  • Professor
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Sanofi-Aventis Australia Pty Ltd